EcoDrugPlus

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSTNIG00000019827
Gene Symbol: SRD5A2A
2 Cross references
207 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSTNIG00000016646
Gene Symbol: SRD5A2B
2 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSTNIG00000015496
Gene Symbol: SOAT1
2 Cross references
210 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSTNIG00000000823
Gene Symbol: SNCA
3 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSTNIG00000018870
Gene Symbol: TACR1
2 Cross references
194 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSTNIG00000013587
Gene Symbol: TACR1B
2 Cross references
193 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSTNIG00000013791
Gene Symbol: TACR2
2 Cross references
196 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSTNIG00000018052
Gene Symbol: TACR3L
2 Cross references
218 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSTNIG00000001503
Gene Symbol: TERT
2 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSTNIG00000008378
Gene Symbol: TBXAS1
2 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSTNIG00000010075
Gene Symbol: TBXA2R
2 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSTNIG00000002865
Gene Symbol: TYMP
3 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).